Non-classical monocytes and monocyte chemoattractant protein-1 (MCP-1) correlate with coronary artery calcium progression in chronically HIV-1 infected adults on stable antiretroviral therapy

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Zungsontiporn, Nath ^a   Tello, Raquel R ^a   Zhang, Guangxiang ^a   Mitchell, Brooks I ^a   Budoff, Matthew ^e   Kallianpur, Kalpana J ^a   Nakamoto, Beau K ^a,b   Keating, Sheila M ^c   Norris, Philip J ^c,d   Ndhlovu, Lishomwa C ^a   Souza, Scott A ^a   Shikuma, Cecilia M ^a   Chow, Dominic C ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Straub Hospital   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER; CALCIUM; CCL2 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CELL COUNT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON CLASSICAL MONOCYTE; OUTCOME ASSESSMENT; PHENOTYPE; SMOKING; AGING; BLOOD; CALCINOSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; COMPLICATION; CORONARY BLOOD VESSEL; CYTOLOGY; HAWAII; HIV INFECTIONS; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGING; ANTI-RETROVIRAL AGENTS; BIOMARKERS; CALCINOSIS; CALCIUM; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; COMORBIDITY; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HAWAII; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84959419785     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149143     Document Type: Article

References (40)

1. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA internal medicine. 2013; 173(8):614-22. doi: 10.1001/jamainternmed.2013.3728 PMID: 23459863
2. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. The Journal of clinical endocrinology and metabolism. 2007; 92(7):2506-12. PMID: 17456578
3. Post WS, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014; 160(7):458-67. doi: 10.7326/M13-1754 PMID: 24687069
4. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. Aids. 2009; 23(9):1059-67. PMID: 19390417
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. The New England journal of medicine. 2005; 352(16):1685-95. PMID: 15843671
6. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on A. Inflammation in atherosclerosis: from pathophysiology to practice. Journal of the American College of Cardiology. 2009; 54(23):2129-38. doi: 10.1016/j.jacc.2009.09.009 PMID: 19942084
7. Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006; 185(1):1-11. PMID: 16297390
8. Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J. HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol. 2013; 20(5):720-8. doi: 10.1177/2047487312447843 PMID: 22556374
9. Zawada AM, Rogacev KS, Schirmer SH, Sester M, Bohm M, Fliser D, et al. Monocyte heterogeneity in human cardiovascular disease. Immunobiology. 2012; 217(12):1273-84. doi: 10.1016/j.imbio.2012.07. 001 PMID: 22898391
10. Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012; 53(1-3):41-57. doi: 10.1007/s12026-012-8297-3 PMID: 22430559
11. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116(16):e74-80. doi: 10.1182/blood-2010-02-258558 PMID: 20628149
12. Libby P, Nahrendorf M, Swirski FK. Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol. 2013; 35(5):553-62. doi: 10.1007/s00281-013-0387-3 PMID: 23839097
13. Han J, Wang B, Han N, Zhao Y, Song C, Feng X, et al. CD14(high)CD16(+) rather than CD14(low) CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr. 2009; 52(5):553-9. PMID: 19950429
14. Baker JV, Hullsiek KH, Singh A, Wilson E, Henry K, Lichtenstein K, et al. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. Aids. 2014; 28(6):831-40. PMID: 24370480
15. Westhorpe CL, Maisa A, Spelman T, Hoy JF, Dewar EM, Karapanagiotidis S, et al. Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals. Immunol Cell Biol. 2014; 92(2):133-8. doi: 10.1038/icb.2013.84 PMID: 24296810
16. Barbour JD, Jalbert EC, Chow DC, Gangcuangco LM, Norris PJ, Keating SM, et al. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy. Atherosclerosis. 2014; 232(1):52-8. doi: 10.1016/j.atherosclerosis. 2013.10.021 PMID: 24401216
17. Shikuma CM, Chow DC, Gangcuangco LM, Zhang G, Keating SM, Norris PJ, et al. Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV. PloS one. 2014; 9(2):e90330. doi: 10.1371/journal.pone.0090330 PMID: 24587328
18. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009; 51(3):268-73. PMID: 19387353
19. Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PloS one. 2012; 7(9):e44454. doi: 10.1371/journal. pone.0044454 PMID: 22970224
20. Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. Aids. 2010; 24 (10):1509-17. PMID: 20505494
21. Floris-Moore M, Fayad ZA, Berman JW, Mani V, Schoenbaum EE, Klein RS, et al. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. Aids. 2009; 23(8):941-9. PMID: 19318907
22. Parra S, Coll B, Aragones G, Marsillach J, Beltran R, Rull A, et al. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation. HIV Med. 2010; 11(4):225-31. doi: 10.1111/j.1468-1293. 2009.00766.x PMID: 19845792
23. Shikuma CM, Barbour JD, Ndhlovu LC, Keating SM, Norris PJ, Budoff M, et al. Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-alpha levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors. AIDS Res Hum Retroviruses. 2014; 30(2):142-6. doi: 10.1089/AID.2013.0183 PMID: 23984974
24. McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ Jr, Kingsley LA, et al. Elevated Levels of Monocyte Activation Markers Are Associated With Subclinical Atherosclerosis in Men With and Those Without HIV Infection. The Journal of infectious diseases. 2015; 211(8):1219-28. doi: 10.1093/infdis/jiu594 PMID: 25362192
25. Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. Aids. 2010; 24(2):243-53. PMID: 19996940
26. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. Journal of the American College of Cardiology. 1998; 31(1):126-33. PMID: 9426030
27. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arteriosclerosis, thrombosis, and vascular biology. 2004; 24(7):1272-7. PMID: 15059806
28. Budoff MJ, Young R, Lopez VA, Kronmal RA, Nasir K, Blumenthal RS, et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology. 2013; 61(12):1231-9. PMID: 23500326
29. Shikuma CM, Seto T, Liang CY, Bennett K, DeGruttola V, Gerschenson M, et al. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses. 2012; 28(8):793-7. doi: 10.1089/AID.2011.0086 PMID: 21978287
30. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. PMID: 12485966
31. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr, et al. Calcified Coronary Artery Plaque Measurement with Cardiac CT in Population-based Studies: Standarized Protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Disk Development in Young Adults (CARDIA) Study. Radiology. 2005; 234(1):34-43.
32. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJ, Detrano R. Quantification of Coronary Artery Calcium using Ultrafast Compted Tomography. Journal of the American College of Cardiology. 1990; 15(4):827-32. PMID: 2407762
33. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009; 29(6):313-26. doi: 10.1089/jir.2008.0027 PMID: 19441883
34. Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical Patrolling Monocyte Function in the Vasculature. Arteriosclerosis, thrombosis, and vascular biology. 2015.
35. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007; 317(5838):666-70. PMID: 17673663
36. Tallone T, Turconi G, Soldati G, Pedrazzini G, Moccetti T, Vassalli G. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J Cardiovasc Transl Res. 2011; 4(2):211-9. doi: 10.1007/s12265-011-9256-4 PMID: 21308491
37. Ulrich C, Heine GH, Gerhart MK, Kohler H, Girndt M. Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant. 2008; 8 (1):103-10. PMID: 18021284
38. Dawson TC, Kuziel WA, Osahar TA, Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 1999; 143(1):205-11. PMID: 10208497
39. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 1999; 19(6):1518-25. PMID: 10364084
40. Zungsontiporn N, Ndhlovu LC, Mitchell BI, Stein JH, Kallianpur KJ, Nakamoto B, et al. Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy. HIV Clin Trials. 2015; 10:1-8.